Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | KDM5B | Q9UGL1 | 4/20 | 0.43 |
| ▸ | KDM5A | P29375 | 3/20 | 0.43 |
| ▸ | KDM4C | Q9H3R0 | 3/20 | 0.43 |
| ▸ | KDM2B | Q8NHM5 | 2/20 | 0.43 |
| ▸ | KDM4A | O75164 | 1/20 | 0.43 |
| ▸ | KDM4B | O94953 | 1/20 | 0.43 |
| ▸ | KDM5C | P41229 | 1/20 | 0.43 |
| ▸ | BRD4 | O60885 | 5/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.38 |
| ▸ | WNT3A | P56704 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4106854 | 0.83 | TRPA1 (0.49) | TRPA1KDM5BKDM4CKDM4AKDM4B | |
| SCHEMBL27925527 | 0.79 | KDM4C (0.62) | KDM5BKDM5AKDM4CKDM2BKDM4A | |
| SCHEMBL1569193 | 0.77 | BRD4 (0.55) | KDM5BKDM5AKDM4CKDM2BKDM4A | |
| SCHEMBL580585 | 0.76 | KDM5B (0.56) | KDM5BKDM5AKDM4CKDM2BKDM4A | |
| SCHEMBL2996936 | 0.74 | KDM5B (0.50) | KDM5BKDM5AKDM4CKDM2BKDM4A | |
| SCHEMBL725762 | 0.74 | TRPA1 (0.58) | TRPA1SMN1; SMN2CYP2C19ALDH1A1LMNA | |
| Benzene SCHEMBL27311002 | 0.74 | TRPA1 (0.58) | TRPA1SMN1; SMN2CYP2C19ALDH1A1LMNA | |
| SCHEMBL4102364 | 0.73 | LMNA (0.50) | TRPA1SMN1; SMN2ALDH1A1LMNAHTT | |
| Hydrochloric Acid SCHEMBL28604607 | 0.73 | KMO (0.36) | TRPA1KDM4CKDM5CCYP1A2LNPEP | |
| SCHEMBL7481175 | 0.72 | MAOB (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8084471-B2 | Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides | YALE UNIVERSITY (US) | 2011-12-27 | — | — | US | disclosed |
| US-8084471-B2 | Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides | YALE UNIVERSITY (US) | 2011-12-27 | — | — | US | disclosed |
| US-8084471-B2 | Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides | YALE UNIVERSITY (US) | 2011-12-27 | — | — | US | disclosed |
| US-20090220586-A1 | PROTEOMIMETIC COMPOUNDS AS INHIBITORS OF THE INTERACTION OF NUCLEAR RECEPTOR WITH COACTIVATOR PEPTIDES | YALE UNIVERSITY (US) | 2009-09-03 | — | — | US | disclosed |
| US-20090220586-A1 | PROTEOMIMETIC COMPOUNDS AS INHIBITORS OF THE INTERACTION OF NUCLEAR RECEPTOR WITH COACTIVATOR PEPTIDES | YALE UNIVERSITY (US) | 2009-09-03 | — | — | US | disclosed |
| US-20090220586-A1 | PROTEOMIMETIC COMPOUNDS AS INHIBITORS OF THE INTERACTION OF NUCLEAR RECEPTOR WITH COACTIVATOR PEPTIDES | YALE UNIVERSITY (US) | 2009-09-03 | — | — | US | disclosed |
| WO-2008030408-A2 | PROTEOMIMETIC COMPOUNDS AS INHIBITORS OF THE INTERACTION OF A NUCLEAR RECEPTOR WITH COACTIVATOR PEPTIDES | YALE UNIVERSITY (US) | 2008-03-13 | — | — | WO | disclosed |
| WO-2008030408-A2 | PROTEOMIMETIC COMPOUNDS AS INHIBITORS OF THE INTERACTION OF A NUCLEAR RECEPTOR WITH COACTIVATOR PEPTIDES | YALE UNIVERSITY (US) | 2008-03-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090220586-A1 | PROTEOMIMETIC COMPOUNDS AS INHIBITORS OF THE INTERACTION OF NUCLEAR RECEPTOR WITH COACTIVATOR PEPTIDES | NCOA1, NCOA2, NCOA3 | TRPA1 4289/4885KDM5B 4110/4885KDM5A 4091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.